Mitotic drivers-inhibitors of the Aurora B Kinase

In this article we review the basis for current anti-mitotic, anti-cancer, therapy and the potential for Aurora B kinase inhibitors as a new differentiated class of agents-mitotic drivers. We review the current understanding of Aurora B inhibition from basic cell biology to inhibitors currently undergoing clinical trials.